Prognostic value of pretreatment lymphocyte percentage in oral cancer: A prospective cohort study.

OBJECTIVE To assess the prognostic role of pretreatment lymphocyte percentage (LY%) for patients with oral squamous cell carcinoma (OSCC). METHODS A large-scale prospective cohort study between July 2002 and March 2021 was conducted. Propensity score-matched (PSM) analysis and inverse probability of treatment weighting (IPTW) analysis were performed to adjust for potential confounders. Using random survival forest (RSF), the relative importance of pretreatment LY% in prognosis prediction was also assessed. RESULTS A total of 743 patients were enrolled and followed up (median: 2.75 years, interquartile range: 1.25-4.42 years). A high pretreatment LY% was significantly associated with better disease-specific survival of patients with OSCC (Hazard ratio [HR] = 0.60, 95% confidence interval [CI]: 0.42, 0.84). The same tendency was observed in PSM (HR = 0.57, 95% CI: 0.38, 0.85) and IPTW analysis (HR = 0.57, 95% CI: 0.40, 0.82). RSF showed that LY% ranked the fifth among importance ranking of all prognostic factors. CONCLUSION Pretreatment LY% showed a moderate predictive ability, suggesting it might be a valuable tool to predict prognosis for patients with OSCC.

[1]  S. M. Ismail,et al.  Prognostic Abilities of Pre- and Post-Treatment Inflammatory Markers in Oral Squamous Cell Carcinoma: Stepwise Modelling , 2022, Medicina.

[2]  Hong Huang,et al.  Lymphocyte percentage as a valuable predictor of prognosis in lung cancer , 2022, Journal of cellular and molecular medicine.

[3]  Yawei Yuan,et al.  The Prognostic Impact of Combined Tumor-Infiltrating Lymphocytes and Pretreatment Blood Lymphocyte Percentage in Locally Advanced Nasopharyngeal Carcinoma , 2022, Frontiers in Oncology.

[4]  L. Ding,et al.  The Ratio of Preoperative Serum Biomarkers Predicts Prognosis in Patients With Oral Squamous Cell Carcinoma , 2021, Frontiers in Oncology.

[5]  Jing Lin,et al.  A novel prognostic Score based on systemic inflammatory Biomarkers for Patients with oral squamous Cell carcinoma. , 2021, Oral diseases.

[6]  Jing Lin,et al.  Prognostic value of preoperative systemic inflammation response index in patients with oral squamous cell carcinoma: Propensity score‐based analysis , 2020, Head & neck.

[7]  L. Cai,et al.  Prognostic value of preoperative lymphocyte-to-monocyte ratio in oral cancer patients and establishment of a dynamic nomogram. , 2020, Oral diseases.

[8]  R. de Bree,et al.  Staging and grading of oral squamous cell carcinoma: An update. , 2020, Oral oncology.

[9]  S. Ramagopalan,et al.  Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants. , 2020, Journal of comparative effectiveness research.

[10]  Pengfei Diao,et al.  Preoperative circulating platelet, neutrophil, and lymphocyte counts predict survival in oral cancer. , 2019, Oral diseases.

[11]  A. Brooks-Wilson,et al.  Genetic variants in genes related to inflammation, apoptosis and autophagy in breast cancer risk , 2019, PloS one.

[12]  S. Warnakulasuriya.  Clinical features and presentation of oral potentially malignant disorders. , 2018, Oral surgery, oral medicine, oral pathology and oral radiology.

[13]  Y. Toiyama,et al.  Clinical burden of preoperative albumin-globulin ratio in esophageal cancer patients. , 2017, American journal of surgery.

[14]  Brian O'Sullivan,et al.  Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.

[15]  T. Shrihari.  Dual role of inflammatory mediators in cancer , 2017, Ecancermedicalscience.

[16]  Y. Liao,et al.  Pretreatment Lymphocyte Monocyte Ratio Predicts Long-Term Outcomes in Patients with Digestive System Tumor: A Meta-Analysis , 2016, Gastroenterology research and practice.

[17]  A. Iizuka,et al.  Immune response-associated gene analysis of 1,000 cancer patients using whole-exome sequencing and gene expression profiling-Project HOPE. , 2016, Biomedical research.

[18]  Hong-zhao Li,et al.  Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis , 2016, Oncotarget.

[19]  G. Heinze,et al.  Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis. , 2015, Cancer treatment reviews.

[20]  W. Jia,et al.  Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma , 2012, Head & neck.

[21]  Wen-Qi Jiang,et al.  Blood Lymphocyte-to-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated with R-CHOP , 2012, PloS one.

[22]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[23]  L. Coussens,et al.  Lymphocytes in cancer development: polarization towards pro-tumor immunity. , 2010, Cytokine & growth factor reviews.

[24]  Stephen R Cole,et al.  Constructing inverse probability weights for marginal structural models. , 2008, American journal of epidemiology.

[25]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[26]  A. Carvalho,et al.  Trends in incidence and prognosis for head and neck cancer in the United States: A site‐specific analysis of the SEER database , 2005, International journal of cancer.

[27]  A. Mantovani,et al.  Smoldering and polarized inflammation in the initiation and promotion of malignant disease. , 2005, Cancer cell.

[28]  J. Johnson,et al.  Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  T. Whiteside,et al.  Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes. , 1998, The Journal of clinical investigation.

[30]  T. Whiteside,et al.  The role of Fas/FasL in immunosuppression induced by human tumors , 1998, Cancer Immunology, Immunotherapy.

[31]  M. Weijtens,et al.  Single chain Ig/gamma gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacity. , 1996, Journal of immunology.

[32]  G. Wolf,et al.  Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study. , 2015, Oral oncology.

[33]  D. McMillan,et al.  Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. , 2010, Future oncology.

[34]  J. Cooper.  Ajcc Cancer Staging Manual , 1997 .